InMode announces additional FDA 510(k) clearance for the Morpheus8 technology

InMode is pleased to announce an additional FDA 510(k) clearance for the Morpheus8 technology. Morpheus8 is the first and only fractional radiofrequency microneedling technology cleared for contraction of soft tissue. The U.S. FDA has cleared the use of the Morpheus8 Applicators for the delivery of fractional radiofrequency use in dermatologic skin procedures where coagulation/contraction of soft tissue or hemostasis is needed. This FDA action expands Morpheus8’s existing FDA clearance, emphasizing the versatility of the technology for physicians and patients.